Acadia Pharmaceuticals | Attività Correnti

Current Assets Cambiamento Data
Acadia Pharmaceuticals USD 616.12M 116.96M 2023-12
ALKERMES USD 1.46B 67.43M 2023-09
Alnylam Pharmaceuticals USD 2.98B 2.76M 2023-12
Corcept Therapeutics USD 458.64M 27.11M 2023-12
Cytokinetics USD 628.05M 66.63M 2023-12
Eisai JPY 659.27B 19.2B 2023-09
Intra Cellular Therapies USD 667.8M 34.63M 2023-12
Moderna USD 10.32B 474M 2023-12
Neurocrine Biosciences USD 1.65B 153.3M 2023-09
Pfizer USD 74.01B 665M 2023-09
Sarepta Therapeutics USD 2.45B 21.76M 2023-09
Ultragenyx Pharmaceutical USD 599.19M 102.95M 2023-09
Vertex Pharmaceuticals USD 14.7B 822.9M 2023-09



Acadia Pharmaceuticals Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2024.